Skip to main content
ODTX
NASDAQ Life Sciences

TPG Discloses 7.8% Stake in Odyssey Therapeutics, Including $25M Private Placement Post-IPO

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$17.39
Mkt Cap
$823.138M
52W Low
$16.405
52W High
$18.06
52W Position info
6.0% above low
Off High info
3.7% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

ODTX is trading near its 52-week low of $16.405 (6.0% above the low).

Summary

TPG and its affiliates disclosed a 7.8% beneficial ownership stake in Odyssey Therapeutics, including a $25 million private placement at the IPO price, signaling strong institutional confidence post-IPO.


Key Events · Ownership and Investor Activity · ODTX

  • Significant Stake Disclosure

    TPG GP A, LLC and its affiliates, including James G. Coulter and Jon Winkelried, disclosed a 7.8% beneficial ownership stake in Odyssey Therapeutics, totaling 3,690,146 shares.

  • Private Placement Investment

    TPG Orazio II, an affiliate, completed a $25 million private placement on May 11, 2026, purchasing 1,388,889 shares at the IPO price of $18.00 per share.

  • Substantial Institutional Backing

    The total beneficial ownership represents a substantial investment, valued at approximately $66.4 million based on the IPO price, indicating strong institutional confidence in the newly public company.

  • Post-IPO Timing

    This filing follows the company's recent initial public offering on May 8, 2026, and provides details on a previously announced private placement, solidifying TPG's position as a major investor.


Analysis · ODTX · Life Sciences

This Schedule 13D filing reveals that TPG, a prominent investment firm, has taken a significant 7.8% stake in Odyssey Therapeutics. A key part of this stake includes a $25 million private placement completed at the IPO price, demonstrating TPG's confidence in the company's valuation and future prospects shortly after its public debut. This substantial investment from a major institutional player provides a strong vote of confidence for the newly public company.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ODTX was trading at $17.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $823.1M. The 52-week trading range was $16.41 to $18.06. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ODTX - Latest Insights

ODTX
Nov 04, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $21.57
Real-time Price: $19.14 info
Change: -$2.43 (-11%) info
Market Cap: $920.019M info
ODTX
Nov 04, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $21.57
Real-time Price: $19.14 info
Change: -$2.43 (-11%) info
Market Cap: $920.019M info
ODTX
Oct 20, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $18.10
Real-time Price: $19.14 info
Change: +$1.04 (+6%) info
Market Cap: $920.019M info
ODTX
Oct 20, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $17.80
Real-time Price: $19.14 info
Change: +$1.34 (+8%) info
Market Cap: $920.019M info
ODTX
Sep 08, 2026, 7:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.97
Real-time Price: $19.14 info
Change: -$7.83 (-29%) info
Market Cap: $920.019M info